A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
Ko-Jiunn LiuTsu-Yi ChaoJang-Yang ChangAnn-Lii ChengHui-Ju Ch'angWoei-Yau KaoYu-Chen WuWei-Lan YuTsai-Rong ChungJacqueline Whang-PengPublished in: Journal of biomedical science (2016)
ClinicalTrials.gov (identifier NCT00154713 ), September 8, 2005.